Latest filing published 04 Mar 2025 for Moderna, Inc., €964k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Paul Sagan (board member) discloses dealings in 4 companies, chiefly Akamai Technologies Inc, Vmware, Inc. and EMC Corp. Between 9 March 2016 and 3 March 2025, the trades on record add up to 51 filings.
Both buying and selling appear: 2 purchases worth €1.9M, against 13 sales worth €20.7M. On balance, insiders were net sellers of €18.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 11 share grants and 20 option exercises. Since January 2025: 1 purchase and no sales on the market.
On 4 March 2025 came the latest disclosure, an open-market purchase for €964k in Moderna, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations